A carregar...
Brusatol, an NRF2 inhibitor for future cancer therapeutic
BACKGROUND: Natural products from herbal medicines have long been investigated for their potentials as cancer therapeutics. Besides the development of several herbal medicine-derived anti-cancer agents, such as paclitaxel, vincristine and podophyllotoxin, many recent laboratory findings demonstrated...
Na minha lista:
| Publicado no: | Cell Biosci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554866/ https://ncbi.nlm.nih.gov/pubmed/31183074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-019-0309-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|